The approval could unlock a big new market opportunity for Wegovy, as MASH is a form of non-alcoholic fatty liver disease (NAFLD) that affects millions of people worldwide and has been billed as pharma's next big growth area, with some analysts predicting a market potentially worth tens of billions of dollars a year
Exenatide long-acting preparation Exenatide LAR, trade name Bydureon, is jointly developed by Amylin and Lily
Seek Medical Advice: If the itching is severe, persistent, or accompanied by other symptoms like swelling or difficulty breathing, contact your doctor immediately
Increased Satiety Signaling Experimental studies suggest activation of GLP-1 pathways may enhance signals associated with fullness, contributing to reduced food intake in some research settings
A JAMA Internal Medicine study highlighted increased gallbladder disease among semaglutide users, and in 2023, the FDA required label changes to reflect serious gastrointestinal risks
we suffer more from imagination than from reality
